Preventing Mother-to-Child Transmission of HIV and HBV

Program Description: To help CDC increase understanding of the effectiveness of using maternal tenofovir containing combination drug during the second and third trimesters of pregnancy for the prevention of mother-to-child transmission of HIV and HBV in co-infected mothers.
Funding Partners:
  • Gilead Sciences, Inc.
Program Partners:
  • CDC's National Center for Chronic Disease Prevention and Health Promotion
Program Location:
  • China